QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 27.99
-- x --
-- x --
-- - --
$ 27.75 - $ 28.05
705,838
na
27.97M
$ 0.19
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-12-2024 12-31-2023 10-Q
3 11-13-2023 09-30-2023 10-Q
4 09-12-2023 06-30-2023 10-K
5 05-09-2023 03-31-2023 10-Q
6 02-13-2023 12-31-2022 10-Q
7 11-10-2022 09-30-2022 10-Q
8 09-21-2022 06-30-2022 10-K
9 05-09-2022 03-31-2022 10-Q
10 02-07-2022 12-31-2021 10-Q
11 11-08-2021 09-30-2021 10-Q
12 09-13-2021 06-30-2021 10-K
13 05-06-2021 03-31-2021 10-Q
14 02-08-2021 12-31-2020 10-Q
15 11-05-2020 09-30-2020 10-Q
16 09-10-2020 06-30-2020 10-K
17 05-11-2020 03-31-2020 10-Q
18 02-06-2020 12-31-2019 10-Q
19 11-07-2019 09-30-2019 10-Q
20 09-12-2019 06-30-2019 10-K
21 05-06-2019 03-31-2019 10-Q
22 02-06-2019 12-31-2018 10-Q
23 11-07-2018 09-30-2018 10-Q
24 09-12-2018 06-30-2018 10-K
25 05-09-2018 03-31-2018 10-Q
26 02-06-2018 12-31-2017 10-Q
27 11-07-2017 09-30-2017 10-Q
28 09-07-2017 06-30-2017 10-K
29 05-08-2017 03-31-2017 10-Q
30 02-08-2017 12-31-2016 10-Q
31 11-07-2016 09-30-2016 10-Q
32 09-07-2016 06-30-2016 10-K
33 05-09-2016 03-31-2016 10-Q
34 02-08-2016 12-31-2015 10-Q
35 11-05-2015 09-30-2015 10-Q
36 09-09-2015 06-30-2015 10-K
37 05-06-2015 03-31-2015 10-Q
38 02-05-2015 12-31-2014 10-Q
39 11-06-2014 09-30-2014 10-Q
40 09-11-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 daily-biotech-pulse-kkr-invests-in-medicine-start-up-revelation-bio-aces-allergic-rhinitis-study-tonix-pharma-ends-covid-19-antiviral-pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

 12-health-care-stocks-moving-in-thursdays-after-market-session

Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company'...

 alliance-global-partners-maintains-buy-on-pluristem-therapeutics-lowers-price-target-to-4

Alliance Global Partners analyst James Molloy maintains Pluristem Therapeutics (NASDAQ:PSTI) with a Buy and lowers the price...

 hc-wainwright-reiterates-on-pluristem-after-encouraging-initial-data

Yesterday Pluristem Therapeutics Inc (NASDAQ: PSTI) announced top-line results from its Phase 3 trial evaluating PLX-PAD in 2...

 pluristem-reports-topline-results-from-its-phase-iii-study-of-muscle-regeneration-following-hip-fracture-surgery

Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI) (“Pluristem” or the “Company”), a leading biotechnology company, today an...

 83-biggest-movers-from-yesterday
83 Biggest Movers From Yesterday
06/09/2022 09:44:29

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion...

 stocks-that-hit-52-week-lows-on-friday

  During Friday's trading, 69 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 73 stocks hit new 52-week lows.

 pluristem-released-plx-r18-hematology-phase-i-study-results-data-show-increase-in-all-blood-lines-and-reduction-in-blood-transfusions-said-plx-r18-reduced-mortality-from-29-to-18-and-was-well-tolerated-with-a-favorable-safety-profile

Pluristem Therapeutics Inc.

 3-penny-stocks-insiders-are-buying

Although Eurozone economy grew 0.3% on quarter during the last three months of 2021, in-line with flash estimates, there were a...

 48-biggest-movers-from-yesterday
48 Biggest Movers From Yesterday
01/21/2022 09:29:26

Gainers  

 65-biggest-movers-from-yesterday
65 Biggest Movers From Yesterday
01/19/2022 09:45:39

Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co ...

 34-stocks-moving-in-tuesdays-mid-day-session

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares gained 37.2% to $6.75 after the company eeceived FDA Breakthrough Device De...

 23-stocks-moving-in-tuesdays-pre-market-session

Gainers

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION